Automated Media Preparation Instrument for Dissolution Testing

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00201

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6632

Additional Details
Set Aside

NONE

Place of Performance

Irvine, California, UNITED STATES

SourceSAM
Documents2
The U.S. Food and Drug Administration (FDA), through its Irvine Medical Products Laboratory (IRVLMP) in Irvine, California, has issued a combined synopsis/solicitation for the acquisition of one (1) Automated Media Preparation Instrument specifically designed for dissolution testing applications. This procurement, identified under solicitation number 75F40126Q00201, is being conducted as a brand-name-or-equal acquisition in accordance with NAICS code 334516 (Analytical Laboratory Instrument Manufacturing). There are no set-aside restrictions associated with this opportunity. The primary objective of this procurement is to enhance the laboratory’s capabilities in preparing dissolution media by automating the process, thereby improving efficiency, accuracy, and reproducibility in laboratory testing. The instrument sought must be capable of automated preparation, heating, degassing, and precise dispensing of dissolution media, fully aligning with the FDA’s minimum technical requirements. Key features required include in-line heating and temperature control, media degassing, onboard programmable operation, comprehensive reporting functionality, and portability. The system must also be compatible with standard U.S. electrical service (115V, 50/60 Hz) and be able to fill dissolution vessels while they are installed on dissolution apparatus. The scope of work encompasses the supply, delivery, installation, operator training, and warranty support for the instrument. The contractor is responsible for providing all necessary labor, materials, equipment, and transportation to ensure a fully operational system. Installation must be performed by an OEM-trained and certified field service engineer and must include operational verification testing to confirm system performance. Additionally, operator training for two users is required to be conducted onsite at the FDA Irvine facility. Deliverables under this contract include the automated media preparation instrument itself, complete installation and qualification, operator training, comprehensive service and warranty documentation, and a minimum twelve (12)-month manufacturer’s warranty. This warranty must cover all parts, labor, travel, technical support, and OEM-certified service. Delivery of the instrument is required within sixty (60) days of contract award, with installation to be completed no later than thirty (30) days after delivery. Final acceptance by the Government will be contingent upon successful delivery, installation, operational verification, completion of training, and confirmation that all solicitation requirements have been met. The procurement is managed by the FDA Office of Acquisition and Grant Services, a federal office under the Department of Health and Human Services. The primary point of contact for this opportunity is Reagan Davis, who can be reached at [email protected] or by phone at 301-796-0910. The notice remains active, with responses due by August 7, 2026. Interested contractors should carefully review the solicitation and its attachments, accessible via the official SAM.gov opportunity posting (https://sam.gov/opp/267f167208bf48fa84c394de64e263c1/view), to ensure their proposed solution meets all technical and performance requirements. This opportunity is well-suited for vendors with expertise in laboratory automation, analytical instrumentation, and FDA-compliant installation and support services.